The ATM variant (rs28904921) was recently compared to other pathogenic missense or truncating variants in the ATM gene in a large cohort of 627,742 hereditary cancer patients and found a higher increased risk of invasive ductal BCa (OR 3.76, 95% CI 2.76–5.21) for carriers of this variant [54]. The gene discussed is ATM; the disease is cancer.